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THE PRIMARY CARE PROVIDER EXPERIENCE IN AN INTERVENTION  
 
TO IMPROVE ADHERENCE TO OPIOID PRESCRIBING GUIDELINES 
 
PHOEBE ANNE CUSHMAN 
 
ABSTRACT 
 
BACKGROUND 
Efforts to curb the opioid epidemic have generated multiple guidelines to 
increase the safety of opioid prescribing for chronic nonmalignant pain (CNMP). 
We performed a qualitative analysis of an intervention (TOPCARE, 
“Transforming Opioid Prescribing in Primary Care”) aimed at improving primary 
care physician (PCP) adherence to opioid prescribing guidelines. We explored 1) 
how TOPCARE influences PCPs’ knowledge, attitudes, and behavior regarding 
the opioid guidelines, 2) how PCPs’ clinical contexts influence implementation of 
TOPCARE, and 3) how characteristics of TOPCARE influence PCPs’ adherence 
to the opioid prescribing guidelines. 
 
METHODS 
We conducted in-person, semi-structured interviews with 22 of 24 intervention 
PCPs from TOPCARE, a cluster RCT at 4 safety-net clinics. The multi-
component TOPCARE intervention consists of a registry of patients who take 
opioids for CNMP, population management by nurse care managers (NCMs), 
education by academic detailers (ADs), and electronic decision support tools. We 
performed thematic analysis of transcribed interviews, double-coding every third 
	  	   viii 
interview. Our conceptual model merged two frameworks: Cabana et al.’s “Why 
don’t physicians follow clinical practice guidelines?” and Rycroft-Malone’s 
“Promoting Action on Research Implementation in Health Services” (PARiHS).  
 
RESULTS 
Themes related to PCP knowledge that emerged from the interviews were 
increased knowledge of the content of the guidelines, increased strategies for 
application of the guidelines, and meaningful feedback. Attitude-related themes 
were PCPs’ personal stances toward the guidelines, increased outcome 
expectancy, reduced anxiety, and perceiving patients who take opioids for CNMP 
as challenging. Behavior-related themes were guideline-concordant prescribing 
becoming routine and increased transfer of tasks to NCMs. PCPs revealed clinic 
resources, clinic leadership, variability of practice style, and historico-political 
context to be important aspects of their clinical contexts that influenced their 
implementation of TOPCARE. The themes TOPCARE as NCM, integration of 
NCM into workflow, NCM as trusted member of the treatment team, supportive 
consultation, and population health approach all emerged as characteristics that 
PCPs found central to the effectiveness of the TOPCARE intervention in 
improving their adherence to opioid guidelines. 
 
CONCLUSION 
An intervention to improve adherence to opioid guidelines increased PCPs’ 
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knowledge and outcome expectancy. PCPs experienced tangible and emotional 
support to reduce variability and enable guideline-concordant care.  
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PROBLEM STATEMENT 
 
 Over the past two decades, the United States has witnessed an “opioid 
epidemic”1 of addiction, diversion, and mortality related to opioid analgesics. The 
rapid rise in opioid misuse parallels the trend of increasing numbers of opioid 
prescriptions for patients with chronic, nonmalignant pain (CNMP).2–6 Because 
PCP (primary care provider) prescribing has been implicated as a factor 
contributing to the epidemic, efforts to curb the epidemic have generated multiple 
new guidelines for PCPs to follow, all aimed at increasing the safety of opioid 
prescribing for CNMP.7–9 PCPs are expected to rapidly incorporate these new 
guidelines into their practices. However, there is a paucity of information on how 
PCPs react to the opioid guidelines and how they go about executing them. We 
analyzed implementation of a multi-component intervention (TOPCARE, 
“Transforming Opioid Prescribing in Primary Care”) to improve primary care 
physician (PCP) adherence to opioid prescribing guidelines. Our qualitative study 
explored how TOPCARE influences PCPs’ knowledge, attitudes, and behavior in 
regard to the opioid guidelines, how PCPs’ clinical contexts affect implementation 
of TOPCARE, and how the TOPCARE intervention impacts adherence to opioid 
prescribing guidelines.  
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LITERATURE REVIEW AND BACKGROUND 
Evolution of the Opioid Epidemic 
 
 Starting in the late 1990s to early 2000s, PCPs in the US generated 
rapidly increasing numbers of prescriptions for opioid analgesics for 
CNMP.2,3,5,6,10 This phenomenon developed for a variety of reasons, including 
pressure from patient advocacy groups to address the under-treatment of pain 
and aggressive marketing by the pharmaceutical industry.11–14 In 2000, the Joint 
Commission on Healthcare Organizations (JCAHO) published new pain 
management standards, lending institutional support for the expanded use of 
opioids.15  
 Unfortunately, an unintended explosion of misuse, addiction, diversion, 
and fatalities related to opioids has followed the rise in opioid prescribing. The 
specific pathways between opioid prescribing by physicians and these negative 
downstream effects have not been fully elucidated, but consist largely of patients 
misusing the opioid analgesics prescribed to them, patients selling or giving away 
their prescribed opioids to others (who subsequently misuse them), and 
unintentional overdoses by patients who take opioid analgesics.2,16 Furthermore, 
a growing subset of patients who developed an addiction to opioid analgesics are 
transitioning to heroin, which, in turn, carries far greater risks, including blood-
borne infections such as Hepatitis C and HIV, and much higher rates of 
overdose.17–23 
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The Opioid Prescribing Guidelines 
 CNMP is one of the most common reasons patients see PCPs; 
accordingly, PCPs are responsible for the majority of opioid prescriptions.14,24 For 
this reason, many of the efforts aimed at addressing our country’s opioid crisis 
have focused on PCP prescribing. Specialty associations and policy makers, 
most notably the Federation of State Medical Boards (2004), American Pain 
Society (2009), the Food and Drug Administration (2012), and the Centers for 
Disease Control and Prevention (2016),8,25–27 have published guidelines of the 
processes they recommend to increase the safety and decrease the risks of 
opioid prescribing. Although the specific components differ slightly from guideline 
to guideline, commonly recommended practices ask PCPs to consider non-
pharmacologic and non-opioid pharmacologic therapies for pain prior to starting 
opioids, regularly screen patients for risks of abuse using risk tools such as the 
ORT (Opioid Risk Tool)28 and the COMM (Current Opioid Misuse Measure),29,30 
regularly assess patients’ functional status with tools such as the PEG 
(Pain/Enjoyment/General Activity) scale,31 sign controlled substance agreements 
with their patients acknowledging that patients will not request early refills or 
obtain controlled substances from multiple providers, collect regular urine drug 
tests, require frequent face-to-face office visits, adhere to strict refill schedules, 
avoid escalating opioid doses above certain ranges, and regularly check state-
based prescription drug monitoring programs (PDMPs).7–9,32  
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Physicians’ Adherence to Practice Guidelines 
 According to the National Academy of Sciences, clinical practice 
guidelines are “statements that include recommendations intended to optimize 
patient care” that “are informed by a systematic review of evidence and an 
assessment of the benefits and harms of alternative care options.”33 With the rise 
of clinical epidemiology and evidence-based medicine in the 1980s and 1990s, 
clinical practice guidelines on various aspects of patient care began to proliferate. 
Unfortunately, history has revealed that the mere publication of guidelines is 
insufficient to change physicians’ practice. Barriers to guideline adherence 
include lack of knowledge of the existence of the guidelines, unfamiliarity with the 
content of the guidelines, lack of skill needed to apply the guidelines, desire to 
maintain the status quo, and systems-level barriers, such as lack of time and 
resources needed to carry out the guidelines.34 
 PCPs face particularly high barriers to adhering to the opioid prescribing 
guidelines. When managing opioids for CNMP, PCPs must answer the 
competing interests of regulatory agencies and potentially demanding patients 
who threaten to give them poor “patient satisfaction” scores,35 all while trying to 
mitigate the physical risks of the medications themselves. There are few 
evidence-based non-opioid pharmacologic or non-pharmacologic treatments for 
chronic pain, and the alternative therapies that do show promise in treating 
chronic pain are rarely covered by insurance plans.7,36,37 In this charged 
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atmosphere, many physicians do not follow opioid prescribing guidelines, even 
with high-risk patients.38–41 
 
Providers’ Experiences of the Opioid Prescribing Guidelines 
 Multiple studies demonstrate the challenges prescribers face in the 
process of opioid prescribing in primary care, including their lack of training in 
safe prescribing practices,42–45 their frustrations communicating with patients who 
have CNMP,46–50 and their poor adherence to opioid prescribing guidelines.38–41 
However, only one study to date has specifically explored PCPs’ reactions to the 
new opioid guidelines. Krebs, et al. (2014) conducted a qualitative study, 
interviewing 14 PCPs and 26 of their patients in one VA Medical Center. Their 
goal was to understand PCPs’ and patients’ attitudes toward the 2009 American 
Pain Society opioid guidelines and identify barriers and facilitators of guideline-
concordant opioid prescribing in primary care.51 The main barriers they identified 
were lack of time and resources, physicians’ dependence on their “gut instincts” 
of patients’ levels of risk rather than on opioid risk tools, and the perception that 
opioid monitoring belonged in the realm of “law enforcement.” The major 
facilitator of adherence to opioid guidelines they found was PCPs’ desire to 
protect their patients from harm.51  
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The TOPCARE Study 
 The TOPCARE study is a cluster randomized clinical trial (RCT) at an 
urban, safety-net academic hospital and three urban community health centers 
that applies the chronic disease model52 and population management techniques 
to help PCPs adhere to opioid prescribing guidelines in primary care settings. 
Full details of the TOPCARE intervention have been previously published.53 In 
brief, PCPs at the four clinical sites were randomized to receive either electronic 
decision support tools alone or a multi-component intervention to aid in 
management of their patients who take opioids for CNMP. The TOPCARE 
intervention comprises multiple pieces that are delivered to the intervention PCPs 
simultaneously; neither the parent RCT nor our qualitative study is designed to 
evaluate the relative efficacy of each piece. Specifically, the multi-component 
intervention consists of 1) an electronic registry of patients who take opioids for 
CNMP, 2) population management by nurse care managers (NCMs), 3) primary 
care provider (PCP) education by academic detailers (ADs), and 4) electronic 
decision support tools.53  
 The electronic registry of patients who take opioids for CNMP is created 
by the study team and managed in real time by the NCM. The registry facilitates 
tracking of data, including opioid prescription refills, total strength of opioids 
prescribed per patient (measured in morphine equivalent daily doses, or 
MEDD54), urine toxicology screening results, and controlled substance 
agreements, across the population of patients who take opioids for CNMP.53  
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 The NCM oversees all patients of PCPs in the intervention arm who are 
taking opioids for CNMP. S/he regularly reviews the registry of patients and 
checks in with the PCP, tailoring his/her level of involvement with each patient to 
the level of risk they present, with the overall goal of achieving guideline-
concordant care for all intervention patients.53 The TOPCARE intervention 
employed three different NCMs, each of whom worked across multiple sites. 
 The AD has a one-time, one-on-one tutorial session with each intervention 
PCP approximately six weeks after enrollment. In that session, the AD reviews 
key principles of safe opioid prescribing (such as a step-wise approach to chronic 
pain that incorporates non-pharmacologic and non-opioid pharmacologic 
therapies prior to initiating opioids) and use of risk assessment tools (such as the 
ORT28 and COMM29,30). Also in that session, the AD reviews that provider’s list of 
patients who take opioids for CNMP, giving the provider the opportunity to review 
any challenging cases.53 The TOPCARE intervention employed two different 
ADs. 
 As noted above, the electronic decision support tools are the only 
component that are available to both the intervention and control PCPs in the 
TOPCARE study. The web-based tools (www.mytopcare.org) include a step-wise 
algorithm for approaching chronic pain, risk assessment tools (including the 
ORT28 and COMM29,30), pain assessments (including the PEG31), substance use 
disorder screening tools (including the Alcohol Use Disorders Identification test, 
or AUDIT,55 and the Drug Use Disorders Identification Test, or DUDIT56), and a 
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calculator (developed by the TOPCARE study team) for interpreting urine drug 
screening test results.53 
 Primary outcomes for the TOPCARE RCT are 1) PCP adherence to opioid 
prescribing guidelines, defined as the presence of a signed controlled substance 
agreement and at least one completed urine drug test for a patient during the 
one-year study period; and 2) opioid misuse by patients, defined as  
two or more early refills by a patient during the study period. All data are 
extracted directly from patient charts via a clinical data warehouse that supports 
the hospital and affiliated community health centers.53 
 
Conceptual Model 
 To explore how the TOPCARE intervention effects change, we developed 
a conceptual model that integrates elements of Cabana et al.’s theory of 
physician adherence to clinical practice guidelines (1999)34 with components of 
the PARIHS (“Promoting Action on Research Implementation in Health Services,” 
2002)57 framework. Cabana, et al. performed a systematic review of the literature 
to develop a theory explaining physicians’ lack of adherence to clinical practice 
guidelines.34 Woolf (1990) had previously proposed a  “knowledge, attitudes, 
behavior” mechanism by which guidelines change practice.58 Building on Woolf’s 
model, Cabana classified the cognitive barriers to guideline adherence he 
identified in the literature as related to “knowledge;” those related to affect he 
labeled “attitudes;” and those related to ability he labeled “behavior.” For 
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example, for any given set of clinical decision-making, physicians may lack 
knowledge that guidelines exist, or they may be aware of the guidelines but not 
familiar enough with their content to make use of them.34 Alternatively, according 
to Cabana, physician attitudes might be to blame—physicians might not agree 
with the specific guidelines or with the concept of following guidelines in general.  
They might hold the attitude that that they personally are incapable of carrying 
out the guidelines or they might not be motivated to even try to carry out the 
guidelines because they are stuck in their old prescribing routines.34 One 
potential attitudinal barrier that Cabana highlights is outcome expectancy, a 
concept from social psychologist Bandura’s self-efficacy theory.59 According to 
Bandura, outcome expectancy is the belief that a behavior will lead to a 
specific outcome.59 Applied to the opioid epidemic, one type of outcome 
expectancy would be a prescriber’s belief that adherence to the opioid 
prescribing guidelines would help ensure patient safety. Finally, according to 
Cabana, physician behaviors can further be restricted by their (real or perceived) 
inability to align the recommendations with patient satisfaction, by lack of 
resources available to carry out the recommendations, or by the impracticality of 
the guidelines themselves.34 In our study, we analyzed how (if at all) aspects of 
the TOPCARE intervention were able to surmount these three types of barriers to 
implementation of opioid guidelines in primary care settings.  
We developed our original interview guide using the Cabana theory for 
understanding adherence, which is focused on how individual physicians change 
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their practices. However, in our first several interviews, we noticed that PCPs 
spontaneously discussed the role of external forces on their individual prescribing 
habits. For example, they brought up how their group’s practice style or how 
news coverage of the opioid epidemic influenced their prescribing. Given that 
these broader scopes of impact on individual prescribing emerged from 
prescribers’ interviews, we decided to add them explicitly—we expanded both 
our conceptual model (Figure 1) and our interview guide (Appendix A). We 
found that the “context” component of the PARiHS framework,57,60,61 which 
represents the complex process by which numerous factors influence the uptake 
of research evidence into clinical practice, served as a useful adjunct for the 
Cabana model.  
The key components of the PARiHS framework are “evidence,” “context,” 
and “facilitation.” In order to account for the fact that physicians do not practice in 
a vacuum, we merged the Cabana model with the “context” component of the 
PARIHS model to create the final conceptual model for our study (Figure 1).  
According to Rycroft-Malone, “context” refers to the environment or setting in 
which change is carried out.57,60,61 Three key features of that context are culture, 
leadership, and measurement.60,61To use the example of opioid prescribing, the 
culture of the clinic, including the style of interaction among the group of 
prescribers, may or may not facilitate adherence to the opioid guidelines. To 
continue that example, a clinic’s leadership might include advocates or 
opponents of the opioid guidelines, which would, in turn, either facilitate or hinder 
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their uptake. Finally, whether or not the clinic mandates that prescribers undergo 
measurement and receive feedback of their practices in relation to the opioid 
guidelines influences whether or not implementation of the guidelines will be 
successful. 
To summarize our conceptual model, we determined that the Cabana 
model alone was insufficient for our study because the TOPCARE study interacts 
with both the individual physician and the medical practice. We therefore merged 
the Cabana model with part of the PARiHS model. We examined the influence of 
the three aspects of “context” as defined by the PARIHS model—culture, 
leadership, and measurement—on the three dimensions of individual physicians’ 
behavior change as defined by the Cabana framework—knowledge, attitudes, 
and behavior. 
 
Summary of Our Study 
 As noted above, there is a dearth of literature on how PCPs react to the 
new opioid guidelines. Krebs et al. (2014) added to that literature by exploring 
PCPs’ and patients’ attitudes toward the opioid guidelines, as well as barriers to 
and facilitators of adherence to these guidelines. Our study builds on the study 
by Krebs, et al. by asking not only how PCPs respond to the opioid guidelines 
themselves, but also how they experience an intervention designed to facilitate 
adherence to the guidelines. Specifically, we analyzed implementation of a multi-
component intervention aimed at improving PCPs’ adherence to opioid 
	  	  
12 
prescribing guidelines.53 We explored 1) how the TOPCARE intervention 
influences PCPs’ knowledge, attitudes, and behavior in regard to the opioid 
guidelines, 2) how PCPs’ particular clinical contexts affect implementation of 
TOPCARE, and 3) how the TOPCARE intervention impacts adherence to opioid 
prescribing guidelines.  
 
Research Questions and Specific Aims 
1) How does the TOPCARE intervention influence PCPs’ knowledge, attitudes, 
and behavior in regard to the opioid guidelines?   
Aim 1.1 à To elucidate how the TOPCARE intervention brings about change in 
PCPs’ knowledge about opioids, chronic pain, and the opioid guidelines 
Aim 1.2  àTo elucidate how the TOPCARE intervention brings about change in 
PCPs’ attitudes toward opioids, chronic pain, patients who take opioids for 
chronic pain, and the opioid guidelines  
Aim 1.3 à To elucidate how the TOPCARE intervention brings about change in 
PCPs’ opioid prescribing behaviors 
 
2) How do PCPs’ clinical contexts facilitate or hinder implementation of the 
TOPCARE intervention?  
Aim 2.1 à To determine, from the perspective of the PCPs, what aspects of the 
environment in which they practice facilitate or hinder implementation of the 
TOPCARE intervention 
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3) What characteristics of the TOPCARE intervention facilitate or hinder 
adherence to the opioid guidelines? 
Aim 3.1 à To determine, from the perspective of the PCPs, what specific 
aspects of the TOPCARE intervention facilitate or hinder adherence to the opioid 
guidelines 
 
Figure 1. Conceptual model.  
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METHODOLOGY 
Overview 
 We conducted in-person, semi-structured qualitative interviews with 22 of 
24 intervention PCPs from the TOPCARE cluster RCT at four safety-net primary 
care clinics. We conducted thematic analysis of the transcribed interviews, 
tracking with NVivo.© Our conceptual model merged two existing frameworks and 
guided a priori codes: Cabana et al.’s theory of physician adherence to clinical 
practice guidelines and Rycroft-Malone’s “Promoting Action on Research 
Implementation in Health Services” (PARiHS). We double-coded every third 
interview and met weekly to reconcile codes. For quality control, we applied the 
consolidated criteria for reporting qualitative research (COREQ).62 
 
Rationale 
 We chose to apply qualitative methodology for two reasons. First, the 
TOPCARE intervention is a novel protocol for helping providers adhere to opioid 
guidelines, and qualitative studies are an excellent means of exploring new 
processes. Second, the TOPCARE RCT has its own quantitative outcomes 
related to guideline adherence (e.g. % of patients with signed patient-provider 
agreements, % of patients with urine toxicology screens). While results of these 
outcomes were not yet known when the qualitative data were collected, 
subsequent analyses have shown significant positive impacts of the TOPCARE 
intervention on guideline-concordant care for chronic opioids,63 further 
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underscoring the importance of understanding how and why the intervention 
successfully impacted provider behavior. Furthermore, we wanted to gather 
PCPs’ rich descriptions of the complex phenomena involved in opioid 
prescribing, including their interactions with patients who have chronic pain and 
their considerations of the benefits and harms of opioids. 
 
Data Source and Data Collection 
 Our data consist of interviews with intervention PCPs from the TOPCARE 
study. As noted above, the PCPs practiced in the primary care clinics of an urban 
safety-net hospital and three urban community health centers. All intervention 
PCPs were recruited for the interview by electronic mail during the last three 
months of TOPCARE study period at their clinics and were scheduled according 
to their availability. Interviews were performed between December 2014 and 
March 2016 in a staggered fashion according to the active study periods at each 
of the 4 study sites. Our study was approved by the Boston University Medical 
Center Institutional Review Board, and all participants provided written informed 
consent. 
 To collect data, the first author conducted in-person, audio-recorded, 
semi-structured interviews with 22 of the 24 intervention PCPs at all 4 sites (one 
PCP declined to be interviewed and another PCP was unavailable). The first 
author was a practicing PCP (and colleague of the PCPs at one site) and 
masters-level student in Health Service Research at the time of the interviews. 
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Interviews were 30 to 45 minutes in length. The interviews (see Appendix A, 
Interview Guide) took place in private rooms at the PCPs’ respective clinical sites 
and asked PCPs about their overall experience with TOPCARE; whether their 
opinions about opioids and/or patients who take opioids for chronic pain have 
changed; their experiences with the academic detailer, the NCM, and the 
electronic decision support tools; what they liked best and least about 
TOPCARE; and if they were aware of any factors that were facilitators of or 
barriers to implementing TOPCARE at their clinical site. After initial interviews 
were conducted, members of our team discussed the responses and clarified 
interview questions and probes as needed.   
 
Data Analysis 
 The interviews were professionally transcribed verbatim. We performed 
thematic analysis of the 22 transcribed interviews, using NVivo© software to 
organize the analysis. Our conceptual model (Cabana/Rycroft-Malone) guided 
development of initial codes, but we were open to themes outside the model. 
Two team members (PC and PR) created the initial codebook and met bi-weekly 
with the senior author (VP) to discuss areas in which we could not achieve 
consensus. The primary coders (PC and PR) double-coded the first three 
interviews; from that point we divided the coding for the remainder of the 
transcripts evenly and also double-coded every third interview in order to ensure 
consistency between the two coders. For those interviews that were individually 
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coded, the primary coder consulted with other members of the coding team for 
any coding decisions that did not seem straightforward. Our process resulted in 8 
of the 22 interviews being double-coded. After coding of all interviews was 
complete, the coding team (PC, PR, and VP) grouped the codes into final themes 
by combining overlapping themes and mapping them back to our original 
research aims. 
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RESULTS 
 
Demographics of PCPs Interviewed 
 Table 1 shows the demographic characteristics of the intervention PCPs 
interviewed. They spanned a broad age range, from those who had recently 
completed training to those who had been practicing for 25 or more years. The 
majority of PCPs were female (64%). Most PCPs were white (64%), with the 
remainder being Asian (18%), African American (18%), or of other (non-Latino) 
race (4%). One PCP was a nurse practitioner; the others were all physicians. 
Twelve PCPs (55%) were from the hospital-based General Internal Medicine 
practice of an urban, safety-net academic medical center (Site A). The remainder 
were divided among three urban community health centers, one (CHC B) serving 
the homeless (18%), another serving a predominantly White population of Irish 
descent (CHC C; 18%), and another serving primarily Vietnamese and African 
American patients (CHC D; 9%).  
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Table 1. PCP Demographics (n = 22)* 
 
Characteristics n (%) 
Age group (y)  
25–35 6 (27%)  
36–40 4 (18%)  
41–45 5 (23%)  
46–50 2 (9%)  
>50 5 (23%)  
Female 14 (64%)  
Race  
White 14 (64%)  
Black 3 (14%)  
Asian 4 (18%)  
Other 1 (5%)  
Provider Type  
MD/DO 21 (95%)  
NP 1 (5%)  
Location  
Academic medical center (Site A) 12 (55%)  
ΦCHC B  4 (18%)  
CHC C  4 (18%)  
CHC D  2 (9%) 
* totals may not equal 100% due to rounding 
ΦCHC= community health center 
 
 
Influence of TOPCARE on PCPs’ Knowledge, Attitudes, and Behavior 
 Appendix B summarizes the key qualitative themes, along with their 
definitions and an example of each theme. In thinking about how TOPCARE 
influences individual PCPs’ adherence to the opioid prescribing guidelines, we 
asked how the TOPCARE intervention influenced PCPs’ knowledge, attitudes, 
and behavior in regard to the guidelines.  
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Knowledge 
 
 Previous to TOPCARE, PCPs had been generally aware of the best 
practices related to opioids; they explained that TOPCARE helped them 
understand more of the specific recommendations. The main way in which PCPs 
reported gaining knowledge of the content of the guidelines was through use of 
the electronic decision support tools: 
[The website] is a nice resource and got me thinking about 
some of the… more standardized tools like PEG 
[Pain/Enjoyment/General Activity scale] and… bringing up 
the more focused or clear-cut assessments, before people 
start [opioids]. [PCP 22] 
 
 PCPs’ interviews revealed that their one-on-one consultations with the 
ADs advanced their knowledge in a more subtle way. Rather than merely 
imparting information, the ADs helped PCPs learn strategies for application of the 
guidelines to their patients. For example: 
[AD 2] had a scoring system that he’d go over with a patient 
each time. I don’t use the exact scoring system, but at least I 
remind myself when I talk to patients, “Based on last time, 
you said your pain was an 8…. How’s your pain now?” [PCP 
11] 
 
Similarly, working over time with the NCMs exposed the PCPs to skillful 
application of the guidelines:  
The way I would always taper [patients’ opioid doses] was, 
“The less pills, the better,” so I would always get rid more of 
the shorter-acting and keep the longer-acting. One thing 
[NCM 3]… educated me on was saying... ‘If they’re gonna 
overdose, it’s more likely with longer-acting, so let’s be 
careful on that. I think you’re probably safer to back off on 
those, and give her more shorter-acting.’ So, it was good to 
have [NCM 3’s] knowledge and show me which is actually 
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the safer way, versus my own. [PCP 16] 
 
 Another important type of knowledge change that emerged from the 
interviews was that of meaningful feedback. Participation in the TOPCARE 
intervention supplied PCPs with valuable data about their patients, including 
evidence of aberrant behavior: 
I think because I have more evidence... about patients’ 
compliance with these medications…I’ve been more apt to 
discontinue... medications when they…seem to be misused. 
So I think... maybe [TOPCARE] hasn’t changed my 
prescribing habits…but I have more feedback. [PCP 2] 
 
Moreover, the feedback the PCPs received was often at odds with the 
impressions of risk they had formed previously about their patients. One PCP 
expressed amazement about how incorrect his gut instinct had turned out to be: 
She’s a patient that I’ve had [for years] and, everything was 
going good and then…TOPCARE came around and [NCM 1 
said]... ‘You’ve never checked urine from this person.” At first 
I [said], “Oh, come on... you know, not... not her.” 
 
(Interviewer): What was it about this patient that made you 
think she was low risk? 
 
The chronicity of the drug, she’s always been very adherent 
with other medical regimens ... she’s always been – or, I 
thought – honest, um... and, uh... you know, she, she’s 
taking care of three young kids, I did not think there was.... a 
possibility that she would do anything aberrant. But, she’s 
actually been very aberrant. I’d considered her one of my... 
you know, stars! [PCP 8] 
 
 In summary, TOPCARE affected PCPs’ knowledge by helping them gain 
increased knowledge of the content of the opioid guidelines, enhanced strategies 
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for applying the guidelines to their patients, and meaningful feedback about their 
patients’ behaviors. 
 
Attitudes 
 
 Although there was no explicit interview question asking about PCPs’ 
opinions of the opioid prescribing guidelines, PCPs’ interviews revealed their 
personal stances toward the opioid guidelines. All PCPs but one voiced their tacit 
approval of the guidelines. For example, PCP 10 said,  
We need to take ownership of what we’re doing, and … we 
need to be comfortable treating pain appropriately. That is 
our job as doctors, right? BUT, we also need to be very, 
very... you know, careful.  
 
 One notable exception to PCPs’ general agreement with the guidelines 
was a particular PCP who criticized the guidelines throughout the interview: 
And then, you know… it’s hard NOT to feel that the system 
that’s being put in place…with testing and all… it’s safer, but 
it’s also badgering patients. It’s definitely a safer way to 
prescribe, but… (sighs) um... it’s not very nice. [PCP 7] 
 
 Through our interviews, we learned that PCPs’ attitudes toward chronic 
pain did not much change under TOPCARE. In response to the question, “Do 
you feel like the way you think about chronic pain, in general, has changed?” 
multiple PCPs simply responded “No.” However, what PCPs did report changing 
were their expectations that the application of the opioid guidelines would yield 
useful results. In other words, their outcome expectancy increased:   
Because of TOPCARE, I’ve become more systematic about 
doing the PEG [Pain/Enjoyment/General Activity] scale and 
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seeing opioids as a trial. And, “If we are not making progress 
on these parameters of increased functional capacity, etc., 
then this isn’t workin’ out… and this may not be the best 
thing for you.” [PCP 2] 
 
 Another PCP described how TOPCARE empowered her to apply the 
guidelines to the process of starting new patients on opioids: 
I have much more of a clear set of questions that I’m asking 
myself, and, in turn, working on with patients before I start…. 
Some of it is just being clear about what our shared goals 
are in using the medication… being much more specific 
together as to what we’re hoping for. So, that way, if there 
are problems down the line, I think that we have a much 
more tangible thing to be discussing. And… it’s taken away 
that element, for the most part, of “he said/she said,” or, tug 
of war with patients.... [PCP 1] 
 
 Another attitudinal change that PCPs reflected had come about because 
of TOPCARE was that of feeling reduced anxiety: 
Before TOPCARE, [opioids] were a source of frustration and 
anxiety... more so than other medications or therapies. And I 
think, because of TOPCARE, I am seeing opioids now [as] 
just another part of the armamentarium... that I can 
dispassionately present to patients…. [PCP 2] 
 
One means by which TOPCARE seemed to reduce anxiety for the PCPs was by 
supplying meaningful feedback, as discussed above. One PCP explained how 
the use of pill counts made her feel more comfortable prescribing opioids:  
The pill counts give you a lot of information, actually. Not 
only about compliance, but also… [they] give you a sense… 
of the patient…. I’ve had patients that really, really fight the 
pill counts…. They’re the ones that eventually, I find some… 
unfortunately [aberrant behavior]. I’ve found that [when] 
patients comply with the pill counts… it’s more comfortable… 
it assures that they’re doing the right thing. [PCP 8] 
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 In their interviews, PCPs uniformly described their patients who take 
opioids for CNMP as challenging. PCP 4 described the tendency of these 
patients to take up a lot of mental space even when they were small in number: “I 
know…compared to the rest of the practice numbers, there are relatively few of 
them? You feel like there’s a million of them, but....“ 
 Although PCPs did not describe TOPCARE as changing their attitudes 
toward patients who take opioids for CNMP, they revealed that TOPCARE 
helped validate their conceptions of their patients as challenging. In turn, this 
validation reduced their anxiety: 
Working with [NCM 1]… was very validating, because… I 
inherited a lot of patients and I thought to myself, “These 
patients are so challenging,” and she said that I did have… a 
lot of very challenging cases... which took off a lot of the 
burden, because suddenly I realized…“Okay. It’s not just my 
emotional reactions to these patients… these are 
challenging patients,” and then it became easier to work with 
them. [PCP 3] 
 
  To review, several important themes related to PCPs’ attitudes emerged 
from the interviews. First, PCPs shared their personal stances toward the opioid 
guidelines, and all but one of them supported the guidelines in general. Second, 
PCPs revealed that TOPCARE did not change their attitudes toward chronic pain 
but it did increase their expectations that application of the opioid guidelines would 
yield useful results. Third, PCPs said that TOPCARE helped reduce their anxiety 
about the opioid prescribing process. And fourth, TOPCARE validated their 
ongoing impressions of patients who take opioids for CNMP as challenging. 
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Behavior 
 
 PCPs described their behavior as changing in two significant ways in 
relation to TOPCARE. First, TOPCARE helped guideline-concordant prescribing 
become routine. One PCP told the story of how TOPCARE helped him make 
application of the guidelines into a “knee jerk reaction”: 
Take for example, yesterday. A person came in… he was 
assaulted… with a baseball bat and [he] had intractable 
migraines… he really just couldn’t function. So, he’s tried the 
NSAIDS and progressed slowly, and nothing’s helping him, 
so I said, “Okay, let’s bite the bullet, let’s do narcotics.” And 
then, the knee jerk reaction was to get the prescription drug 
monitoring program, the contract…. [PCP 11] 
 
 Second, instead of attempting to carry out all components of the opioid 
guidelines by themselves, TOPCARE allowed PCPs to transfer tasks to the 
NCM. The transfer of responsibility for specific functions to the NCMs, in turn, 
helped PCPs become confident that tasks were complete: 
One thing that stands out a lot is use of confirmatory [urine 
drug] testing… Before [TOPCARE], there were barriers to 
how to actually get that done. Now it’s quite easy just to 
send it to the NCM, and say, “Please confirm this...” [PCP 3] 
 
Moreover, the transfer of tasks provided PCPs more much-needed time for their 
other duties: 
[NCM 1] allowed me … to get a good detailed history about 
their pain, but [also] allowed me more time to also focus on 
some of the other chronic issues that I need to address… so, 
[the NCM] has helped from a time point of view, too. [PCP 5] 
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Characteristics of the Clinical Environment 
 The aforementioned themes all relate to how TOPCARE changed the 
knowledge, attitudes, and behaviors of individual PCPs. Since the primary aim of 
the TOPCARE intervention was systems-level change, we also examined how 
the settings in which PCPs practice, from the micro-environment of the clinical 
work space to the macro-environment of cultural and political forces, affected 
PCPs’ uptake of TOPCARE. 
 PCPs commented that, at the most basic level, implementation of 
TOPCARE required certain clinic resources. Although not explicitly asked about 
finances, PCPs seemed to be aware that money could be a factor limiting long-
term sustainability of TOPCARE. When asked, “Are there any other things that 
you wanted to add about your experience?” PCP 5 replied, “Hopefully we can 
find some funding to keep people here, doing [TOPCARE].” Physical space for 
the NCM to meet with patients was also an issue that arose from PCP’s 
interviews: 
Space is a huge barrier… Where does she meet with 
people? Often times, she’ll come in at the end of my visit and 
talk to the patients, which sometimes works. Sometimes it’s 
like, “I need you to be moving [along]….” [PCP 13] 
 
 Whereas money and physical space emerged as potential barriers to 
TOPCARE, clinic leadership emerged as a facilitator to its implementation. Many 
PCPs explained that the buy-in for TOPCARE was strong because clinic 
leadership had already primed them to improve the safety of opioid prescribing: 
	  	  
27 
I think that it’s... been happening [at our clinic] over the last 
two years, and I think part of that’s been why TOPCARE 
works…. We already had… a staff champion of opioid 
prescriptions, so she’s been… giving lots of talks and… 
providing education… She’s done all of our chronic pain 
stuff, even before TOPCARE.... [PCP 22] 
 
 PCPs also revealed that variability among prescribing styles within a 
practice hindered guideline implementation; they felt that TOPCARE reduced that 
variability:  
We’d had some prescribers in the past who were… 
“cowboys”…you know, really prescribing a lot. And [with 
TOPCARE]... as a group, we are more together about the 
way we prescribe. [PCP 17] 
 
 One of the main driving forces for variability that PCPs discussed was 
what they termed “inherited patients.” They described “inherited patients” as 
high-risk patients who came to PCPs on inappropriate doses of opioids that had 
been started by other providers. Previous to TOPCARE, PCPs had struggled to 
align the pain regimens for these “inherited patients’” with opioid prescribing 
guidelines, but, with the guidance of the NCMs, they were able to identify 
aberrant behavior and/or titrate medications to appropriate levels. Some of these 
patients had transferred to their practices from outside (sometimes out-of-state) 
clinics: 
We did have somebody who… moved from Tennessee to 
here. She was on higher doses of fentanyl than she needed 
to be, then [NCM 2 and I] tapered her off, and that was really 
helpful…. [PCP 18] 
 
 Perhaps more challenging, PCPs also described the transfer of patients 
from one PCP to another within the same practice. TOPCARE did not completely 
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correct this phenomenon, but it did provide a blueprint for change:  
There are patients that will want to transfer doctors, [within] 
this practice, even when their old doctor’s still here. And, 
that’s a situation that I think we need to have a clinic-based 
policy on…. I think TOPCARE, if anything, gives us a 
framework [for] how we, as a clinic practice, in general, can 
do pain management. ‘Cause it’d really be best, I think, if we 
were more uniform. [PCP 3] 
 
 All of the above-mentioned themes relate to how various characteristics of 
the clinical environment affected implementation of TOPCARE. However, PCPs’ 
interviews also revealed that forces beyond the walls of the clinic influenced 
them. When asked if their opioid prescribing practices had changed as a result of 
TOPCARE, PCPs consistently had trouble separating the effects of TOPCARE 
from the wider historico-political context in which they practiced. One PCP 
responded,  
Probably not. I don’t think so…. I mean, I guess, well, I take 
that back. I mean, probably not too much [because of] my 
enrollment…. But at the same [time]… people were dying on 
the streets of opiate overdoses. So, I think… that probably 
would have raised my radar… if the TOPCARE study wasn’t 
going on… [PCP 4] 
 
 Several PCPs referred specifically to the effects of the Massachusetts 
legislation (passed March 2016 and put into effect the same month) limiting the 
number of pills prescribed for initial opioid prescriptions and requiring PCPs to 
check the PDMP for each and every opioid prescription64 as influencing their 
practice:  
It’s hard to tease out what things have changed in the last 
two years, because of the TOPCARE study; versus because 
of, you know... the new laws that have been passed in 
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Massachusetts, the other updates I’ve been getting. [PCP 
22] 
 
Other PCPs referenced the historical position of Boston in relationship to 
the opioid crisis: 
I know everywhere has an opioid problem. But in [CHC C], 
we feel like we have this…increased spotlight of the 
problem? .… I think everyone has… the feeling like, “Oh, 
yes, it’s a problem everywhere, now? But it started with us.” 
And… it’s been part of the landscape here.... I think it makes 
it harder in our interactions with the patients…. I think, it 
motivates the providers…. [PCP 20] 
 
 To summarize, clinic resources, clinic leadership, variability among 
prescribing styles within a clinic, and the wider historico-political background 
were the main contextual features that PCPs described as affecting 
implementation of the TOPCARE intervention. 
 
Characteristics of the TOPCARE Intervention 
 Because our study was, in part, an implementation analysis, we also 
wanted to explore, from the perspectives of the PCPs, what characteristics of the 
TOPCARE intervention facilitated or hindered adherence to the opioid guidelines. 
In other words, if the intervention were found to be successful in increasing 
guideline-concordant prescribing, then what aspects of TOPCARE made it 
successful? 
 One of the most striking themes that emerged from our interviews was 
that of TOPCARE as Nurse Care Manager. When asked about TOPCARE as a 
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whole, PCPs very commonly referred to the NCM as if s/he embodied the entire 
intervention. This identification of TOPCARE as a whole with the NCM appeared 
frequently in response to the very first (intentionally broad) interview question, 
“What has it been like to participate in TOPCARE?” 
Having [NCM 1] and [NCM 2] here has been like night or 
day…. [PCP 1] 
 
[NCM 2] has been great…. I love the idea of the program, 
but I feel like having him here... has made a huge 
difference… [PCP 18] 
 
It’s been helpful to have [NCM 3] from [Site A] to go over 
patients…. [PCP 15] 
 
 In addition to the NCMs’ expertise in strategic application of the guidelines 
(discussed above in the section on knowledge), another way in which NCMs 
helped PCPs adhere to opioid guidelines was through their integration into the 
existing workflow. One of the key features of that integration was the physical 
proximity of the NCM. Having her on-site and available in-person was something 
that numerous PCPs considered essential. In response to the question, “How 
was communication with [NCM 1]?” PCP 11 replied, “Very easy. She’s around 
the corner.” In contrast, another PCP remarked on the location of the NCM on a 
different floor as being a barrier to access: 
I didn’t end up with as much interaction with the TOPCARE 
nurse as I was thinking…. Partly, I think that’s because she... 
physically is located on the second floor, so she ended up 
spending more time with the second floor participants than 
the first floor participants. [PCP 22] 
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 When asked if there were any improvements that could be made to TOPCARE, a 
PCP at a study site that did not have full-time access to a NCM expressed 
frustration: 
I think one thing that would be helpful is knowing [NCM 3]’s 
schedule a little bit more clearly… and then I could even just 
start scheduling people with her, because otherwise…I’m not 
using her as much as maybe I could be. [PCP 13] 
 
 In addition to physical proximity, the NCM’s ability to communicate with 
both PCPs and patients was one of the critical elements that facilitated 
integration of the NCM into the workflow. One PCP explained how seamlessly 
the NCM fit into the daily management of patients: 
We don’t have a set time meeting. It’s really just in the 
workflow of the day. Obviously [NCM 2] will reach out to me 
if people need refills. But… you know…if there’s something 
that is troubling him… and, more often it troubles him than it 
troubles me, because he’s talked to the patients…. And, 
when people haven’t shown up for appointments, he’s 
reached out to them. [PCP 18] 
 
In contrast to the NCMs’ excellent communication with PCPs and patients, 
one PCP commented that communication between the NCM and the clinic 
nursing staff did not always occur smoothly: 
There was, in general, a good interface between the 
TOPCARE nurse and our nursing staff, but there were 
frequently times when it wasn’t clear to our nurses on the 
team what the intention was, about someone’s prescription. 
[PCP 9] 
 
 Yet another way in which PCPs described NCMs as central to the 
effectiveness of TOPCARE was their role as trusted members of the treatment 
team. The NCMs showed genuine compassion for the PCPs’ patients:  
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[NCM 1] has gotten to know these patients and, yeah, it’s 
been quite nice to see the relationships that she’s developed 
with these patients that are therapeutic relationships.  
[PCP 2] 
 
 One PCP referred to how skillfully the NCM introduced himself to patients, 
even when no one had told them the NCM would be contacting them: 
When [NCM 2] came [to TOPCARE], he... called patients… 
without me telling them that, “You’re gonna get a phone call 
from somebody.” And they seemed receptive to it... and to 
what he was trying to offer them. [PCP 18] 
 
 Because they had earned the patients’ trust, NCMs were able to convince 
the patients that changes to their opioid regimens were in their best interests: 
I told you about the partner who had been using [my 
patient’s opioids]? It was [NCM 1] that spoke with [the 
couple], and they showed up [to me] afterwards and were... 
completely apologetic that, “We weren’t gonna do that 
anymore, we weren’t gonna do ANY sort of narcotic 
anymore, because of the safety issue….” It was a... positive 
interaction. It wasn’t confrontational on either side.... They 
were glad that they could stay here... and we would be their 
doctors, so, that went pleasantly well.... [PCP 5] 
 
 In addition to offering support for the patients, PCPs described TOPCARE 
as offering supportive consultation for themselves as they navigated the opioid 
prescribing process. Previous to TOPCARE, they had felt they had to make 
decisions about opioids in isolation, but with TOPCARE, they could make them in 
partnership with an outside expert who was on their side: 
What’s REALLY been helpful is having a nurse working with 
me and partnering with me, with my patients who are on 
chronic pain meds, who can see them as well as me seeing 
them. It gives me a second opinion, it gives me somebody 
else’s eyes... [PCP 16] 
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In addition to offering the PCPs camaraderie and expertise, the NCMs also 
helped reinforce the PCPs’ decisions with the patients:   
Well, it, it’s good to… know that [NCM 1] is… reinforcing the 
same message with some of my more challenging 
patients…. The patient knows that he or she will talk to 
[NCM 1] and [NCM 1] is going to tow the same exact line…. 
[PCP 11] 	  
 The PCPs described both NCMs and ADs as providing supportive 
consultation. One PCP reflected on which parts of the AD session had been most 
beneficial: 
It was helpful to see what was in the brochure…. But, that 
wasn’t as helpful as being able to bring a couple of cases 
and consult about them directly. That was the most helpful... 
[PCP 1] 
 
The consultations offered by the NCMs and PCPs were supportive, in part, 
because they helped legitimize the complexity of opioid prescribing. When asked 
to think back on the AD session, one PCP recalled a conversation with the AD 
about a specific patient:  
 
So [the AD session] was really helpful to me, because… I 
remember exactly which patient…. he was on chronic 
opioids, and he was struggling with alcohol. He hit just a 
downward spiral, and with the gabapentin, so there were 
many things going on with him, and I really just wanted... the 
feedback, and advice and counseling of somebody like [AD 
1] because she’s just... so experienced.… Because I feel like 
every individual patient is unique.… And it’s nice to have 
somebody like a [AD 1] who is, in spite of her experience, 
still saying, “You know... at the end of the day… we can try 
these things…. But, you know…I can’t tell you definitively 
that this is going to work.” [PCP 15] 
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 As discussed above, one of the main ways TOPCARE was able to 
facilitate change was offering the PCPs expertise with a personal touch. Another 
means by which it facilitated change was structural in nature; it established a 
population health approach through which PCPs could organize their opioid 
prescribing practices: 
Now, I feel much more comfortable about my whole panel of 
opioid prescribing because I’m so much more in control of 
it… in a much more structured way…. Because, feeling more 
in control about the whole process makes each of the 
individual patient visits so much less anxiety-provoking…. 
[PCP 1] 
 
 In summary, TOPCARE as NCM, integration of NCM into workflow, NCM 
as trusted member of treatment team, supportive consultation, and population 
health approach were the themes that emerged from PCP interviews describing 
which characteristics of the TOPCARE intervention facilitated their adherence to 
the opioid guidelines. 	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DISCUSSION 	  
 Our interviews with the TOPCARE PCPs provide insight into PCPs’ 
experiences in regard to both the TOPCARE intervention specifically and the 
opioid prescribing guidelines in general. In order to examine these implications, 
we can review our main conclusions from two perspectives: 1) practical, relating 
to the process of implementing either an intervention such as TOPCARE or the 
opioid prescribing guidelines themselves; and 2) theoretical, shedding new light 
on the sequence of events that lead to individual behavior change and/or 
systems level change. 
Practical Implications 
 In our discussion of the practical implications of our findings, we will first 
address components of the TOPCARE intervention that PCPs described as most 
salient, namely the website and the NCM. We will examine what factors the 
PCPs felt made the website and NCM successful, and also explore how these 
two components could be adapted in order to implement TOPCARE in different 
settings. Following our discussion of how TOPCARE could be carried out in 
diverse settings, we will address our study’s ramifications for implementation of 
the opioid prescribing guidelines in general.  
Implementation of the TOPCARE Intervention 
 
 Although three components of the TOPCARE intervention (the NCM, AD, 
and registry) are relatively resource-intensive, the website is low-cost and low-
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maintenance. In their interviews, PCPs reported that referring to the electronic 
decision support tools on the website on an as-needed basis taught them a 
stepped approach to pain treatments, risk assessment tools, and interpretation of 
urine toxicology screening. By helping to increase PCPs’ knowledge of the 
content of the opioid prescribing guidelines over time, the website has the 
potential to bring about changes in prescribing behavior that last beyond the 
study period. One way to potentially increase the use of the electronic decision 
support tools found in the TOPCARE website would be to embed them directly in 
electronic medical records (EMRs), so that the tools automatically become visible 
when a PCP prescribes an opioid medication or views urine toxicology lab results 
in the EMR. According to a 2009 Cochrane systematic review, such “point of 
care” tools are slightly to moderately effective in influencing both process and 
outcome measures of adherence to clinical practice guidelines.65 
 The PCPs viewed the NCM as the central component of TOPCARE, often 
responding in their interviews as if TOPCARE and the NCM were one and the 
same. In order to successfully replicate the TOPCARE intervention in other 
settings, it is critical to understand what particular features made the NCM so 
effective in the eyes of the PCPs. According to the PCPs, physical proximity, 
coordination with the rest of the clinic team, and formation of trusting alliance with 
patients were central to the success of the NCM. 
 The PCPs cited examples of the NCM’s physical proximity as paramount, 
to the point that they felt those who worked on the same floor as the NCM 
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benefitted more than those who worked one floor down. At the clinics in which 
the NCM was not on-site full time, PCPs expressed frustration about not being 
able to reach him/her. This result mirrors that of a 2007 study in which Dorr, et al. 
used factor analysis to identify which features of a multi-modal team-based care 
management intervention at seven clinics in the Intermountain Healthcare 
system in Utah were most closely linked to desired changes in measures for 
diabetes and cardiovascular disease. Dorr’s team found that higher amounts of 
“face-to-face time” between nurse care managers and patients were significantly 
associated with improvements in both process and outcome measures.66 
Examining our results in light of this study raises the question of whether a 
version of TOPCARE with only phone- or email-based access to a NCM might 
lead to decreased PCP satisfaction with the intervention, and possibly even to 
worse patient outcomes.   
 Another feature that PCPs cited as essential to the performance of the 
NCM was coordination with the site’s clinical staff. This finding resonates with 
those of Friedman et al.’s 2016 qualitative study of “care coordinators” (a role 
filled by nurses, social workers, and other health care workers) at 25 different 
primary care clinics designated as Patient Centered Medical Homes (PCMHs) 
across the United States. In that study, care coordinators reported that “strong 
relationships with staff” was one of the key facilitators that made their work 
effective and also emphasized the value of being part of the team at their clinic 
sites.67 Therefore, future renditions of TOPCARE might benefit from additional 
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training for both NCM and clinic staff to fully integrate the NCM into the existing 
workflow. 
 In addition to physical proximity and coordination with the team, PCPs 
cited the ability of the NCM to form a trusting alliance with the patient as integral 
to his/her effectiveness. PCPs expressed surprise that most patients rapidly 
accepted the NCM as an advocate rather than as an impediment. Similarly, 
another qualitative study based on observations of interactions between 
TOPCARE NCMs and patients found that “developing a therapeutic relationship 
with the patient” was one of the primary strategies the NCM used to navigate 
aberrant patient behavior.68 Our results also reinforce those of Krebs et al., who 
described patients in one VA health system as most accepting of opioid 
monitoring when they “trusted that the physician had their best interests in 
mind.”51 However, our study extends the importance of the therapeutic alliance 
from that between the PCP and patient to that between the NCM and patient. 
From our results, it follows that training NCMs in building a therapeutic 
relationship and in the development of other skills related to patient-centered 
care would be an important component of carrying out TOPCARE in other 
settings. It is also possible that the nurturing, supportive demeanor of the NCM 
could have a beneficial effect on patients’ perceived pain, although examination 
of this hypothesis would require a separate study. In 2001, DiBlasi, et al. 
published a systematic review of the influence of “context effects” on health 
outcomes, including levels of pain. They found that providers’ delivery of 
	  	  
39 
“emotional care” (which they described as being “warm, friendly, and reassuring”) 
was significantly associated with reduced pain in studies of shoulder and dental 
pain.69 	  
Implementation of the Opioid Prescribing Guidelines 
 
 Thus far, our discussion has considered the practical implications of 
implementing TOPCARE in diverse settings. Our study also holds broader 
ramifications for implementation of the opioid prescribing guidelines in general.  
We will now explore how PCPs’ reflections on meaningful feedback, attitudes 
toward the opioid prescribing guidelines, and “inherited patients” inform a deeper 
understanding of the opioid prescribing guidelines. 
 One of the dominant themes in our study was that of meaningful feedback. 
TOPCARE PCPs said they received valuable data from the ADs and NCMs 
about their patients’ opioid dosages, presence or absence of signed patient-
provider agreements, and results of urine drug screens and pill counts. The value 
of these data lay in their capacity to guide the care of their patients. Furthermore, 
the data imparted to PCPs was often at odds with their “gut impressions” of their 
patients. This finding demonstrates how TOPCARE is capable of overcoming 
one of the main barriers to adherence to opioid guidelines identified by Krebs, et 
al. — that PCPs believed they could rely on their general impressions of risk for 
their patients on opioids rather than relying on data.51 Our study reinforces the 
idea that, just as PCPs monitor the blood sugar and other key parameters of their 
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patients with diabetes, they require access to data on their patients who take 
opioids for CNMP in order to make informed management decisions. 
 The theme of meaningful feedback echoes the concept of “measurement” 
(later renamed “evaluation”) in the PARiHS model. According to Rhycroft-
Malone, “measurement is both part of the research process that generates 
evidence on which to base practice and part of the evaluation or feedback 
process that demonstrates whether or not changes in practice are 
appropriate/effective/efficient.” Furthermore, meaningful feedback fits into the 
schema of “audit and feedback” that is a common element of quality 
improvement work. According to a 2012 Cochrane systematic review, delivery of 
audit and feedback data 1) multiple times and 2) verbally as well as in writing are 
two factors that make this process more effective.70 It is possible that the PCPs in 
our study found the TOPCARE data valuable, in part, because their delivery met 
both of these criteria. 
 Another major theme of our study was that of PCPs’ personal stances 
toward the opioid guidelines. Our interviews revealed that PCPs held pre-formed 
attitudes toward the opioid guidelines, patients who take opioids for CNMP, and 
chronic pain. Surprisingly, the TOPCARE intervention did not much change these 
deep-seated stances. All but one of the twenty-two PCPs shared their implicit 
approval of the opioid prescribing guidelines. One PCP, in contrast, voiced 
explicit disapproval of both the TOPCARE intervention and the opioid guidelines, 
calling “the system that’s being put in place…. a safer way to prescribe, but…not 
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very nice.” In their systematic review, Cabana et al. described “lack of agreement 
with guidelines” as one of physicians’ major attitudinal barriers to adherence to 
clinical practice guidelines.34 Physicians’ opinions that guidelines in general 
interfere with physicians’ autonomy and that patient discomfort outweighs any 
benefits of the guidelines were among the reasons cited for this “lack of 
agreement.”34 Numerous studies subsequent to Cabana’s review have confirmed 
“lack of agreement” as a potent barrier to adherence to practice guidelines. For 
example, in a 2014 systematic review of qualitative and quantitative studies of 
barriers to hypertension guidelines, Khatib et al. found that “lack of trust in the 
evidence on which guidelines were based upon” was a prominent barrier.71 Given 
the current controversies surrounding opioids as well as the fact that many of the 
current opioid prescribing guidelines are founded on limited evidence,27,72 it is 
likely that the attitudes of this outlier interviewee represent those of a substantial 
minority of PCPs. Our study suggests that additional strategies should be 
developed in order to gain the trust of PCPs who are wary of the opioid 
guidelines and to engage them in safer opioid prescribing efforts. In the case of 
the PCP who worries that the guidelines are “not nice” for patients, sharing 
patients’ experiences of the guidelines might help gain the PCP’s endorsement. 
 Negative PCP attitudes toward the opioid guidelines are one potential 
obstacle to guideline-concordant care. Our study also highlights the “inherited 
patient” as another barrier to implementing the opioid guidelines. In their 
interviews, PCPs described “inherited patients” as those who arrive at their 
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practice upon transfer from other PCPs within the practice or from outside 
practices. These patients are high-risk for opioid misuse and/or already on 
inappropriate regimens of opioids. Previous to TOCPARE, PCPs described 
themselves as recognizing the treatment plans of “inherited patients’” as unsafe, 
but lacking the skills to alter them. In other words, the ongoing “inheritance” of 
patients had prompted PCPs to perpetuate the cycle of guideline non-concordant 
prescribing. The tutelage of the NCMs and ADs in TOPCARE did help the 
intervention PCPs bring their inherited patients into guideline-concordant care, 
but our study suggests that PCPs require additional training on a more 
comprehensive level. In 2009, Gourlay and Heit revised their original “Universal 
Precautions” recommendations for risk assessment of patients who take opioids 
for CNMP to include a specific plan for “inherited patients,”73 and, in 2017 Alford, 
et al. published a “Beyond the Guidelines” educational article with advice on how 
to manage of a patient on very high doses of opioids who had transferred her 
care from an outside provider.74 Moreover, there has been increasing attention in 
the medical literature toward the process of “opioid tapering” for patients on high 
opioid doses and/or who have high risk.75,76 However, the opioid prescribing 
guidelines themselves lack any specific recommendations for management of the 
“inherited patient.”25–27,72 Another implication of our study is that the guidelines 
should be updated to include explicit instructions on management of these 
“inherited patients.” 
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Theoretical Implications 
 Until this point, our discussion has focused on the practical lessons our 
study provides for implementing the TOPCARE intervention in other settings and, 
more broadly, for implementing the opioid prescribing guidelines in general. We 
now turn to those implications of our study that contribute to the expansion of 
existing theory about the uptake of clinical practice guidelines in general.   
 One theoretical implication of our study concerns the role of strategic 
application of knowledge. Specifically, our study reinforces the idea that the 
acquisition of knowledge is necessary but not sufficient to create long-lasting 
change in prescribing habits. Although not discussed in the Cabana model, our 
interviews reveal that a thorough understanding of how to apply that knowledge 
is perhaps even more critical. For example, a provider may consider a set of 
guidelines to appear straightforward when he sees them on paper, but then later 
struggle to apply the guidelines to the patient standing in front of him. To that 
end, both the NCM and the AD helped PCPs learn how to strategically apply the 
opioid prescribing guidelines. Our results raise the possibility that strategic 
application of guidelines, a concept that would fall between the two categories 
“knowledge” and “attitudes” in the Cabana model, might be a critical step in the 
pathway toward developing adherence to guidelines.  
 As noted above, TOPCARE did not much change PCPs’ attitudes about 
the opioid guidelines, patients who take opioids for CNMP, or chronic pain. 
However, it did increase their outcome expectancy, a concept borrowed from 
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Bandura’s social cognitive theory59 as adapted by Cabana et al.34 In other words, 
TOPCARE helped PCPs view the opioid guidelines as instruments that would 
enhance their care rather than as perfunctory tasks required to meet external 
regulations. Our study therefore helps further delineate the mechanism by which 
outcome expectancy contributes to guideline adherence. Specifically, we found 
that outcome expectancy is closely linked to both strategic application of the 
guidelines and meaningful feedback, two themes we have already reviewed. For 
example, if a PCP successfully learns how to collect and interpret urine 
toxicology screens in her patient population (strategic application of the 
guidelines), then she receives valuable information about whether or not her 
patients are taking the opioids as prescribed and/or taking any illicit substances 
(meaningful feedback). With these changes in knowledge, she gains an attitude 
of increased outcome expectancy, or the conviction that repeated application of 
the guidelines will again yield useful results. Our study’s findings about strategic 
application of knowledge, meaningful feedback, and outcome expectancy expand 
the original understanding of outcome expectancy as presented by Cabana, et al. 
Additional research is needed to explore these steps in the learning process, 
 Another theme from our study that has theoretical implications is that of 
the population health approach. In their interviews, PCPs reported that that the 
structure of TOPCARE allowed them to think about their patients who take 
opioids for CNMP in a more systematic way, thus helping them feel more “in 
control of the whole process” of opioid prescribing. Multiple studies have shown 
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that application of a population health model can help improve measures of 
quality, cost, patient satisfaction, and/or provider satisfaction.77–79 Our study 
suggests that one of the means by which a population health approach enhances 
provider satisfaction is helping them feel more in command of their panels of 
patients who have specific chronic illnesses. Additional investigation is needed to 
examine the connection between a population health approach to patient care 
and provider satisfaction.  
 A final theoretical implication of our study is that it supports the idea that 
any intervention aimed at improving PCP adherence to guidelines must take into 
account both the individual level of behavior change and the wider context in 
which PCPs practice. Interestingly, after we had already designed our qualitative 
study and created our conceptual model merging the Cabana model and the 
PARiHS framework, Harvey and Kitson (two of Rycroft-Malone’s long-term 
collaborators) published a revised implementation science framework, called 
“Integrated PARiHS” or “i-PARiHS.”80 The original PARiHS framework57,61 did not 
give specific attention to the individuals whose behavior the proposed 
intervention was intended to change. One of the major additions in the revised “i-
PARiHS” framework is the new “recipient” construct, which takes into account the 
role of both individuals and teams in the uptake of an intervention.80  
 Whereas the i-PARiHS framework now includes the role of the individual, 
the Cabana theory has also been modified to include the role of cultural context. 
In their analysis of uptake of nutrition guidelines in intensive care units (ICUs) in 
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Canada, Cahill, et al. expanded the Cabana theory to include attention to 
“institutional characteristics,” including “ICU culture.”81 Cabana himself 
subsequently commended the expanded theory, noting that, “Further work is 
needed to understand guideline adherence from its traditional emphasis on 
individual behavior to the interaction between healthcare providers, guideline 
characteristics, and the organizational context.”82 
Limitations 
 Our results should be considered in light of several limitations. First, the 
PCPs were interviewed at the end of the one-year study period at each of their 
respective clinical sites. This timing could have limited their recall of some 
elements of the intervention—especially the academic detailing session, which 
occurred early in the study period. Second, because the interviewer was a PCP 
herself and a colleague of several of the interviewees, it is possible that social 
desirability bias could have affected some responses. Third, neither this 
qualitative study nor the TOPCARE RCT was designed to allow comparison of 
the relative effectiveness of each of the components (electronic decision tools, 
registry, NCM, AD) of the intervention. Fourth, the details of the qualitative study 
were created after the TOPCARE RCT had already been rolled out, meaning 
that, by design, we were not able to map our qualitative results back to the 
quantitative outcomes of the parent study. Finally, although we consider our 
inclusion of PCPs from all four clinical sites (each serving diverse patient 
populations) a strength of our study, it should be noted that all sites were urban. 
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Because of this and because of the nature of any qualitative study, our results 
may not be transferable to other settings, especially to rural settings.  
Conclusion 
 The primary contribution of this study is a detailed exploration of the PCP 
experience in an intervention to improve adherence to opioid prescribing 
guidelines. Whereas previous studies have identified barriers to guideline-
concordant prescribing, ours is the first study that we are aware of to examine 
how an intervention surmounts some of these barriers in order to effect change. 
In particular, we found that the TOPCARE intervention increased PCPs’ 
knowledge and outcome expectancy. Furthermore, we found that PCPs 
experienced tangible and emotional support to help reduce variability and carry 
out guideline-concordant care. Future research should also address the 
important perspective of patients in these improvement processes, including their 
reactions to additional monitoring and the adequacy of their pain control. Our 
findings may be used to inform the design and implementation of future 
interventions to improve the safety of opioid prescribing while also making the 
prescribing process more gratifying for PCPs. 
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APPENDIX A: Interview Guide 
 
1) What has it been like to participate in the TOPCARE study? 
o How (if at all) has the way you think about opioids changed since 
you have been involved in the study? 
o How (if at all) has the way you think about patients with chronic 
pain changed since you have been involved in the study?  
o How (if at all) have your opioid prescribing practices changed since 
you have been involved in the study? 
 
2) You might recall that about 6 weeks after you were enrolled in the study, 
you met one-on-one with _____ (Academic Detailer) about your opioid 
prescribing practices.  What was it like to meet with  _____ (Academic 
Detailer)? 
o What did you take away from the session?  
§ Did you learn anything about yourself?  
o Did anything that you learned affect your patient management?  
§ How so? 
o Were you familiar with the process of academic detailing before 
TOPCARE? 
o Did your opinion of academic detailing change after the session?  
o What was it like for the academic detailers to be your colleagues? 
 
3) What was it like to work with, _____, the Nurse Care Manager? 
o How did you work with the NCM as part of the study?  
o How often did you use the NCM as a resource?  
o What aspects of a case would make you want to call the NCM?  
o What were the barriers to contacting the NCM when you wanted to 
consult about a patient?  
o How useful did you find the results of NCM appointments (nursing 
assessment note, pill counts, UDS results)?  
o After the NCM met with a patient and gave you the above results 
and her point of view on a case, did you do things differently? 
§ How so? 
o Did you and the NCM ever disagree about how to handle a 
patient’s case? 
• If so, how was this disagreement resolved?  
 
4) At the beginning of the study, you were introduced to the TOPCARE 
website (mytopcare.org).  
o If you have used the website, how have you used it? 
o If you have not used the website, why not?  
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o What suggestions for improvement would you make to the 
TOPCARE website?  
 
5) What parts of the TOPCARE study have you found most helpful?   
o Why? 
 
6) What were the barriers  (if any) to implementing TOPCARE at your clinic?  
Were there aspects of your clinic that you think made the TOPCARE 
intervention run smoothly? 
 
7) If you were able to keep some parts of TOPCARE at your clinic after the 
study is over, what parts would you like to see stay on? 
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APPENDIX B: Summary of Qualitative Themes 	  
 
Specific Aim 
 
 
Theme and Definition 
 
Example 
 
 
1.1 Knowledge 
 
Theme: Increased knowledge of 
content of the guidelines 
 
Definition: TOPCARE increased 
PCPs’ knowledge of the basic 
content in the opioid prescribing 
guidelines 
 
 
“[The website] is a nice resource and got 
me thinking about some of the… more 
standardized tools like PEG 
[Pain/Enjoyment/General Activity scale] 
and… bringing up the more focused or 
clear-cut assessments, before people start 
[opioids].” 
 
  
Theme: Increased strategies for 
application of the guidelines  
 
Definition: TOPCARE increased 
PCPs’ knowledge of strategies 
for interacting with patients in the 
process of opioid prescribing 
 
 
(Interviewer) “Was there anything that you 
took away from the [academic detailing] 
session?” (Subject) “[AD] had a scoring 
system that he’d go over with a patient each 
time. I don’t use the exact scoring system, 
but at least I remind myself when I talk to 
patients, ‘Based on last time, you said your 
pain was an 8…. how’s your pain now?’”  
 
  
Theme: Meaningful feedback  
 
Definition: TOPCARE gave 
PCPs meaningful feedback 
about their patients’ behavior, 
including aberrant behavior 
 
 
“I think because I have more evidence... 
about patients’ compliance with these 
medications…I’ve been more apt to 
discontinue... medications when 
they…seem to be misused. So I think... 
maybe [TOPCARE] hasn’t changed my 
prescribing habits…but I have more 
feedback.”  
 
 
 
1.2 Attitudes 
 
Theme: Personal stance toward 
opioid guidelines  
 
Definition: PCPs described their 
personal viewpoints about the 
opioid guidelines in general 
 
 
“And then, you know… it’s hard NOT to 
feel that the system that’s being put in 
place…with testing and all… it’s safer, but 
it’s also badgering patients. It’s definitely a 
safer way to prescribe, but …. (sighs) um... 
it’s not very nice.”  
 
 
Theme: Increased outcome 
expectancy  
 
Definition: PCPs voiced belief 
that performance of the 
components of the opioid 
guidelines will lead to desired 
outcomes (i.e. increases in 
 
“Well, I think….I’ve sort of broken out of the 
monthly prescription habit… so realizing 
that... well, maybe for this patient, we can 
prescribe every week…. instead of every 
month…. And using that as... an interim, 
sort of trial period for the patient, to see if 
they are really going to comply, you know. 
That... WAS a new concept for me.” 
	  	  
51 
patient safety) 
 
 
 
Theme: Reduced anxiety 
 
Definition: TOPCARE reduced 
PCPs’ anxiety about the opioid 
prescribing process 
 
“I think... opioids were always something 
special… Before TOPCARE [they] were a 
source of frustration and anxiety... more so 
than other medications or therapies. And I 
think, because of TOPCARE, I am seeing 
opioids now [as] just another part of the 
armamentarium... that I can 
dispassionately present to patients….” 
 
 
Theme: Challenging nature of 
patients who take opioids for 
CNMP  
 
Definition: PCPs characterized 
their patients who take opioids for 
CNMP as a challenging group of 
patients 
 
 
“I know, in the end, compared to the rest of 
the practice numbers, there’re relatively 
few of them? You feel like there’s a million 
of them, but...”  
 
 
 
1.3 Behavior 
 
Theme: Guideline-concordant 
prescribing becoming routine 
  
Definition: TOPCARE helped 
PCPs learn to incorporate the 
opioid guidelines into their routine 
practices 
 
 
“Take for example, yesterday. A person 
came in…he was assaulted… with a 
baseball bat and [he] had intractable 
migraines…he really just couldn’t function. 
So, he’s tried the NSAIDS and progressed 
slowly, and nothing’s helping him, so I said, 
‘Okay, let’s bite the bullet, let’s do 
narcotics.’ And then, the knee jerk reaction 
was to get the prescription drug monitoring 
program, the contract….” 
 
 
 
 
Theme: Transfer of tasks to NCM 
 
Definition:  Instead of attempting 
to carry out all components of the 
opioid guidelines by themselves, 
TOPCARE, allowed PCPs to 
transfer responsibility of specific 
functions to the NCM  
 
 
“One thing that stands out a lot is use of 
confirmatory [urine drug] testing…. Before, 
there were barriers to how to actually get 
that done. Now it’s quite easy just to send 
it to the NCM, and say, ‘Please confirm 
this...’” 
 
 
2.1 
Characteris-tics 
of practice 
environment 
 
Theme: Clinic resources 
 
Definition: Clinic resources 
(including finances and space) 
were or were not adequate to 
support execution of TOPCARE 
and/or the opioid guidelines 
 
“Space is a huge barrier… Where does 
she meet with people? Often times, she’ll 
come in at the end of my visit and talk to 
the patients, which sometimes works. 
Sometimes it’s like, ‘I need you to be 
moving...’ 
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Theme: Clinic leadership 
 
Definition: Leadership of the 
clinic where PCPs practices 
influenced how TOPCARE was 
implemented and/or adherence to 
opioid guidelines 
 
 
“I think that it’s... been happening [at our 
clinic] over the last two years, and I think 
part of that’s been why TOPCARE 
works…. We already had…a staff 
champion of opioid prescriptions, so she’s 
been, you know, giving lots of talks and… 
providing education… She’s done all of our 
chronic pain stuff, even before 
TOPCARE...”  
 
 
 
 
Theme: Variability of practice 
style  
 
Definition:  Variability vs. 
consistency of practice style 
within a group of PCPs influenced 
how TOPCARE was implemented 
and/or adherence to opioid 
guidelines 
 
 
“We’d had some prescribers in the 
past who were…’cowboys’…you 
know, really prescribing a lot. And 
[with TOPCARE]... as a group, we 
are more together about the way 
we prescribe.” 
 
Theme: Historico-political context  
 
Definition: Cultural forces 
beyond the walls of the practice 
impacted the way PCPs prescribe  
 
 
(Interviewer) “Do you think that your 
prescribing practices have changed since 
you have been in [TOPCARE]? (Subject) 
“Probably not. I don’t think so. …. I mean, I 
guess, well, I take that back. I mean, 
probably not too much [because of] my 
enrollment….. But at the same [time]… 
people were dying on the streets of opiate 
overdoses. So, I think… that probably 
would have raised my radar … if the 
TOPCARE study wasn’t going on…” 
 
 
 
3.1 
Characteristics 
of TOPCARE 
intervenion  
 
Theme: TOPCARE as NCM 
 
Definition:  PCPs referred to the 
NCM as if s/he embodied the 
entire intervention 
 
 
(Interviewer) “First question is, what has it 
been like to participate in TOPCARE?” 
(Subject) “Having [NCM 1] and [NCM 2] 
here has been like night or day….” 
 
Theme: Integration of NCM into 
workflow 
 
Definition: PCPs described 
facilitators of and barriers to 
integrating NCM into workflow 
 
“There was, in general, a good interface 
between the TOPCARE nurse and our 
nursing staff, but, there were frequently 
times when it wasn’t clear to our nurses on 
the team what the intention was, about 
someone’s prescription.” 
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Theme: NCM as trusted member 
of treatment team 
 
Definition: NCMs demonstrated 
compassion for patients who 
take opioids for CNMP while 
facilitating adherence to opioid 
guidelines  
 
 
“… she has gotten to know these patients 
and, yeah, it’s been quite nice to see the 
relationships that she’s developed with 
these patients that are therapeutic 
relationships.” 
 
Theme: Supportive consultation 
 
Definition: TOPCARE provided 
PCPs support for the decisions 
they made about opioid 
prescribing 
 
“What’s REALLY been helpful is having a 
nurse working with me and partnering with 
me, with my patients who are on chronic 
pain meds, who can see them as well as me 
seeing them. It gives me a second opinion, 
it gives me somebody else’s eyes...” 
 
 
Theme: Population health 
approach 
 
Definition: TOPCARE facilitated 
a population health approach for 
caring for patients who take 
opioids for CNMP 
 
“….now I feel much more comfortable about 
my whole panel of opioid prescribing 
because I’m so much more in control of it… 
in a much more structured way… Because, 
feeling more in control about the whole 
process makes each of the individual 
patient visits so much less anxiety-
provoking…” 
 
	  	  
54 
BIBLIOGRAPHY 	  
List of Abbreviated Journal Titles 
 
Alcohol Clin Exp Res……………. Alcoholism, Clinical and Experimental Research 
Am J Public Health………………………………  American Journal of Public Health 
Ann Intern Med…………………………………………… Annals of Internal Medicine 
Arch Intern Med………………………………………… Archives of Internal Medicine 
Clin J Pain………………………………………………… The Clinical Journal of Pain 
Cochrane Database Syst Rev….  The Cochrane Database of Systematic Reviews 
Cult Anthropol.......…………………………………………...… Cultural Anthropology 
Drug Alcohol Depend……………………………….. Drug and Alcohol Dependence 
Eur Addict Res………………………………………… European Addiction Research 
Implement Sci……........…………………..…………….. Implementation Science: IS 
Int J Drug Policy…………………………... The International Journal on Drug Policy 
Int J Qual Health Care....................International Journal for Quality in Health Care 
J Altern Complement Med…. Journal of Alternative and Complementary Medicine 
J Am Board Fam Med………… Journal of the American Board of Family Medicine 
J Gen Intern Med……………………………… Journal of General Internal Medicine 
J Nurs Care Qual……………………………………. Journal of Nursing Care Quality 
J Pain Off J Am Pain Soc………………………………………… The Journal of Pain 
J Subst Abuse Treat……………………….  Journal of Substance Abuse Treatment 
JAMA……………………  JAMA: The Journal of the American Medical Association 
JAMA Internal Med…………………………………………... JAMA Internal Medicine 
JPEN J Parenter Enteral………. JPEN: Journal of Parenteral and Enteral Nutrition 
Med Care Res Rev MCRR………….. Medical Care Research and Review: MCRR 
Palliat Med………………………………………………………….. Palliative Medicine 
Pain Med…………………………………………………………………. Pain Medicine 
Patient Educ Couns……………………………… Patient Education and Counseling 
Pharmacoepidemiol Drug Saf……………Pharmacoepidemiology and Drug Safety 
Psychol Rev…………………………………………………….. Psychological Review 
Qual Health Care QHC………………………………… Quality in Health Care: QHC 
Qual Saf Health Care……………………………….. Quality & Safety in Health Care 
Subst Abuse……..………………………………………………….. Substance Abuse 
Teach Learn Med……………………………….. Teaching and Learning in Medicine 
West J Med………………………………………… The Western Journal of Medicine 
 
	  	  
55 
1.  CDC Online Newsroom - Press Release: November 1, 2011. 
http://www.cdc.gov/media/releases/2011/p1101_flu_pain_killer_overdose.ht
ml. Accessed June 13, 2016. 
2.  Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain 
relievers by frequency of past-year nonmedical use United States, 2008–
2011. JAMA Intern Med. 2014;174(5):802–803.  
3.  Barry DT, Irwin KS, Jones ES, et al. Opioids, chronic pain, and addiction in 
primary care. J Pain Off J Am Pain Soc. 2010;11(12):1442–1450.  
4.  Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, 
Jones TF. High-risk use by patients prescribed opioids for pain and its role 
in overdose deaths. JAMA Intern Med. 2014;174(5):796–801.  
5.  Wright ER, Kooreman HE, Greene MS, Chambers RA, Banerjee A, Wilson J. 
The iatrogenic epidemic of prescription drug abuse: county-level 
determinants of opioid availability and abuse. Drug Alcohol Depend. 
2014;138:209–215.  
6.  Beauchamp GA, Winstanley EL, Ryan SA, Lyons MS. Moving beyond misuse 
and diversion: the urgent need to consider the role of iatrogenic addiction in 
the current opioid epidemic. Am J Public Health. 2014;104(11):2023–2029.  
7.  Dowell D, Haegerich TM, Chou R. CDc guideline for prescribing opioids for 
chronic pain—united states, 2016. JAMA. 2016;315(15):1624–1645.  
8.  Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic 
opioid therapy in chronic noncancer pain. J Pain Off J Am Pain Soc. 
2009;10(2):113–130.  
9.  Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain 
Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic 
non-cancer pain: Part I—evidence assessment. Pain Physician. 2012;15(3 
Suppl):S1–65. 
10.  Han H, Kass PH, Wilsey BL, Li C-S. Increasing trends in Schedule II opioid 
use and doctor shopping during 1999–2007 in California. 
Pharmacoepidemiol Drug Saf. 2014;23(1):26–35.  
11.  Rich BA. Physicians’ legal duty to relieve suffering. West J Med. 
2001;175(3):151–152. 
	  	  
56 
12.  US Pain Foundation Press Kit. http://www.uspainfoundation.org/wp-
content/uploads/2015/12/uspainfoundation_presskit.pdf. Accessed February 
16, 2017. 
13.  Van Zee A. The Promotion and Marketing of OxyContin: Commercial 
Triumph, Public Health Tragedy. Am J Public Health. 2009;99(2):221–227. 
doi:10.2105/AJPH.2007. 
14.  Institute of Medicine Committee on Advancing Pain Research. Relieving 
Pain in America: A Blueprint for Transforming Prevention, Care, Education, 
and Research. 2011. http://www.iom.edu/Reports/2011/Relieving-Pain-in-
America-A-Blueprint-for-Transforming-Prevention-Care-Education-
Research.aspx. Accessed June 1, 2016. 
15.  Phillips DM. D. JCAHO pain management standards are unveiled:Joint 
Commission on Accreditation of Healthcare Organizations. JAMA. 
2000;(284):426–429. 
16.  Results from the 2011 NSDUH: Summary of National Findings, SAMHSA, 
CBHSQ.  
https://www.samhsa.gov/data/sites/default/files/Revised2k11NSDUHSumm
NatFindings/Revised2k11NSDUHSummNatFindings/NSDUHresults2011.ht
m. Accessed February 16, 2017. 
17.  Stumbo SP, Yarborough BJH, McCarty D, Weisner C, Green CA. Patient-
reported pathways to opioid use disorders and pain-related barriers to 
treatment engagement. J Subst Abuse Treat. 2017;73:47–54.  
18.  Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D. “Every ‘never’ 
I ever said came true”: transitions from opioid pills to heroin injecting. Int J 
Drug Policy. 2014;25(2):257–266.  
19.  Cicero TJ, Kuehn BM. Driven by prescription drug abuse, heroin use 
increases among suburban and rural whites. JAMA. 2014;312(2):118–119.  
20.  Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The Changing Face of Heroin Use 
in the United States: A Retrospective Analysis of the Past 50 Years. JAMA 
Psychiatry. 2014;71(7):821.  
21.  Volkow ND. America’s Addiction to Opioids: Heroin and Prescription Drug 
Abuse | National Institute on Drug Abuse (NIDA). 
http://www.drugabuse.gov/about-nida/legislative-activities/testimony-to-
congress/2014/americas-addiction-to-opioids-heroin-prescription-drug-
abuse. Published May 14, 2014. Accessed June 12, 2015. 
	  	  
57 
22.  Jones CM. Heroin use and heroin use risk behaviors among nonmedical 
users of prescription opioid pain relievers - United States, 2002–2004 and 
2008–2010. Drug Alcohol Depend. 2013;132(1–2):95–100.  
23.  Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: 
national demographic trends in hospitalizations for heroin- and opioid-
related overdoses, 1993–2009. PLoS One. 2013;8(2):e54496.  
24.  Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by 
Different Types of Medicare Prescribers. JAMA Intern Med. 2016;176(2): 
259–261. 
25.  Federation of State Medical Boards (FSMB). Model Policy for the Use of 
Controlled Substances for the Treatment of Pain. The Federation, 2004. 
26.  United States Food and Drug Administration. FDA Blueprint for Prescriber 
Education for Extended-Release and Long-Acting Opioid Analgesics. 
October 2015. 
http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass. 
Accessed May 1, 2016. 
27.  Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for 
Chronic Pain-United States, 2016. JAMA. March 2016.  
28.  Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated 
patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6): 
432–442.  
29.  Butler SF, Budman SH, Fernandez KC, et al. Development and validation of 
the Current Opioid Misuse Measure. Pain. 2007;130(1–2):144–156.  
30.  Butler SF, Budman SH, Fanciullo GJ, Jamison RN. Cross Validation of the 
Current Opioid Misuse Measure (COMM) to Monitor Chronic Pain Patients 
on Opioid Therapy. Clin J Pain. 2010;26(9):770–776.  
31.  Krebs EE, Lorenz KA, Bair MJ, et al. Development and Initial Validation of 
the PEG, a Three-item Scale Assessing Pain Intensity and Interference. J 
Gen Intern Med. 2009;24(6):733–738.  
32.  Washington State Agency Medical Directors’ Group. Washington 
Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain: An 
educational aid to improve care and safety with opioid therapy. 2010. 
http://www.agencymeddirectors.wa.gov/files/opioidgdline.pdf. Accessed 
November 16, 2015. 
	  	  
58 
33.  Medicine I of. Clinical Practice Guidelines We Can Trust.; 2011. 
https://www.nap.edu/catalog/13058/clinical-practice-guidelines-we-can-trust. 
Accessed February 17, 2017. 
34.  Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical 
practice guidelines? A framework for improvement. JAMA. 1999;282(15): 
1458–1465. 
35.  Zgierska A, Miller M, Rabago D. Patient Satisfaction, Prescription Drug 
Abuse, and Potential Unintended Consequences. JAMA. 2012;307(13): 
1377–1378. 
36.  Cleary-Guida MB, Okvat HA, Oz MC, Ting W. A Regional Survey of Health 
Insurance Coverage for Complementary and Alternative Medicine: Current 
Status and Future Ramifications. J Altern Complement Med. 2001;7(3):269–
273.  
37.  Turk DC, Wilson HD, Cahana A. Treatment of chronic non-cancer pain. The 
Lancet. 2011;377(9784):2226–2235.  
38.  Sekhon R, Aminjavahery N, Davis CN, Roswarski MJ, Robinette C. 
Compliance with opioid treatment guidelines for chronic non-cancer pain 
(CNCP) in primary care at a Veterans Affairs Medical Center (VAMC). Pain 
Med. 2013;14(10):1548–1556.  
39.  Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of 
opioid risk reduction strategies in primary care even for high risk patients 
with chronic pain. J Gen Intern Med. 2011;26(9):958–964.  
40.  Krebs EE, Ramsey DC, Miloshoff JM, Bair MJ. Primary care monitoring of 
long-term opioid therapy among veterans with chronic pain. Pain Med. 2011; 
12(5):740–746.  
41.  Khalid L, Liebschutz JM, Xuan Z, et al. Adherence to prescription opioid 
monitoring guidelines among residents and attending physicians in the 
primary care setting. Pain Med. 2015;16(3):480–487.  
42.  Keller CE, Ashrafioun L, Neumann AM, Van Klein J, Fox CH, Blondell RD. 
Practices, perceptions, and concerns of primary care physicians about 
opioid dependence associated with the treatment of chronic pain. Subst 
Abuse. 2012;33(2):103–113.  
43.  Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns 
about management of chronic pain in community clinic populations. J Gen 
Intern Med. 2006;21(6):652–655.  
	  	  
59 
44.  Starrels JL, Fox AD, Kunins HV, Cunningham CO. They don’t know what 
they don’t know: internal medicine residents’ knowledge and confidence in 
urine drug test interpretation for patients with chronic pain. J Gen Intern 
Med. 2012;27(11):1521–1527.  
45.  Chen JT, Fagan MJ, Diaz JA, Reinert SE. Is treating chronic pain torture? 
Internal medicine residents’ experience with patients with chronic 
nonmalignant pain. Teach Learn Med. 2007;19(2):101–105.  
46.  Matthias MS, Bair MJ. The patient-provider relationship in chronic pain 
management: where do we go from here? Pain Med. 2010;11(12):1747–
1749.  
47.  Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. “I’m 
not abusing or anything”: patient-physician communication about opioid 
treatment in chronic pain. Patient Educ Couns. 2013;93(2):197–202.  
48.  Matthias MS, Parpart AL, Nyland KA, et al. The patient-provider relationship 
in chronic pain care: providers’ perspectives. Pain Med. 2010;11(11):1688–
1697.  
49.  Crowley-Matoka M, True G. No One Wants to be the Candy Man: 
Ambivalent Medicalization and Clinician Subjectivity in Pain Management. 
Cult Anthropol. 2012;27(4):689–712. 
50.  Bergman AA, Matthias MS, Coffing JM, Krebs EE. Contrasting tensions 
between patients and PCPs in chronic pain management: a qualitative 
study. Pain Med. 2013;14(11):1689–1697.  
51.  Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias 
MS. Barriers to guideline-concordant opioid management in primary care–a 
qualitative study. J Pain Off J Am Pain Soc. 2014;15(11):1148–1155.  
52.  Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for 
patients with chronic illness. JAMA. 2002;288(14):1775–1779. 
53.  Lasser KE, Shanahan C, Parker V, et al. A Multicomponent Intervention to 
Improve Primary Care Provider Adherence to Chronic Opioid Therapy 
Guidelines and Reduce Opioid Misuse: A Cluster Randomized Controlled 
Trial Protocol. J Subst Abuse Treat. 2016;60:101–109.  
54.  Svendsen K, Borchgrevink P, Fredheim O, Hamunen K, Mellbye A, Dale O. 
Choosing the unit of measurement counts: The use of oral morphine 
equivalents in studies of opioid consumption is a useful addition to defined 
daily doses. Palliat Med. 2011;25(7):725–732.  
	  	  
60 
55.  Lundin A, Hallgren M, Balliu N, Forsell Y. The use of alcohol use disorders 
identification test (AUDIT) in detecting alcohol use disorder and risk drinking 
in the general population: validation of AUDIT using schedules for clinical 
assessment in neuropsychiatry. Alcohol Clin Exp Res. 2015;39(1):158–165.  
56.  Berman AH, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug 
Use Disorders Identification Test (DUDIT) in criminal justice and 
detoxification settings and in a Swedish population sample. Eur Addict Res. 
2005;11(1):22–31.  
57.  Rycroft-Malone J. The PARIHS framework–a framework for guiding the 
implementation of evidence-based practice. J Nurs Care Qual. 
2004;19(4):297–304. 
58.  Woolf SH. Practice guidelines: a new reality in medicine. III. Impact on 
patient care. Arch Intern Med. 1993;153(23):2646–2655. 
59.  Bandura A. Self-efficacy: toward a unifying theory of behavioral change. 
Psychol Rev. 1977;84(2):191–215. 
60.  Kitson A, Harvey G, McCormack B. Enabling the implementation of evidence 
based practice: a conceptual framework. Qual Health Care QHC. 
1998;7(3):149–158. 
61.  Rycroft-Malone J, Kitson A, Harvey G, et al. Ingredients for change: 
revisiting a conceptual framework. Qual Saf Health Care. 2002;11(2):174–
180. 
62.  Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative 
research (COREQ): a 32-item checklist for interviews and focus groups. Int 
J Qual Health Care. 2007;19(6):349–357.  
63.  Liebschutz, Jane M.; Xuan, ZIming; Shanahan Christopher W.; LaRochelle, 
Marc; Keosaian Julia.; Beers, Donna; Guara, George; O’Connor, Kristen; 
Alford, Daniel P.; Parker, Victoria; Weiss, Roger D.; Samet, Jeffrey H.; 
Crosson, Julie; Cushman, Phoebe A., Lasser, Karen E.; Improving 
Adherence to Chronic Opioid Therapy Guidelines to Reduce Opioid Misuse 
in Primary Care: A Cluster Randomized Controlled Trial. (In press, JAMA 
Internal Medicine). 
64.  Commonwealth of Massachusetts, House, No. 4056, An Act Relative to 
Substance Use Treatment, Education and Prevention. 
http://www.massmed.org/advocacy/key-issues/opioid-abuse/conference-
committee-report--an-act-relative-to-substance-use,-treatment,-education-
and-prevention-(pdf)/. Published March 8, 2016. Accessed March 24, 2017. 
	  	  
61 
65.  Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. 
The effects of on-screen, point of care computer reminders on processes 
and outcomes of care. In: Cochrane Database of Systematic Reviews. John 
Wiley & Sons, Ltd; 2009.  
66.  Dorr DA, Wilcox A, Jones S, Burns L, Donnelly SM, Brunker CP. Care 
management dosage. J Gen Intern Med. 2007;22(6):736–741.  
67.  Friedman A, Howard J, Shaw EK, Cohen DJ, Shahidi L, Ferrante JM. 
Facilitators and Barriers to Care Coordination in Patient-centered Medical 
Homes (PCMHs) from Coordinators’ Perspectives. J Am Board Fam Med. 
2016;29(1):90–101.  
68.  Allison V. Langea MD, Orlaith D. Heymanna MA, Jane M. Liebschutza MD 
MPH, Karen E. Lassera,b MD MPH, Pamela Coreyd MSN RN, Christopher 
W. Shanahana MD MPH, Hannah S. Kopinskia BA, Jawad M. Husaina BS, 
Phoebe A. Cushmana MD, Victoria A. Parkerc EdM DBA. Communication 
Between Nurse Care Managers and Patients Who Take Opioids for Chronic 
Pain: Strategies for Exploring Aberrant Behavior. (Under review, Journal of 
Opioid Management). 
69.  DiBlasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context 
effects on health outcomes: a systematic review. Lancet. 2001;357(9258): 
757–762. 
70.  Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on 
professional practice and healthcare outcomes. Cochrane Database Syst 
Rev. 2012;(6):CD000259.  
71.  Khatib R, Schwalm J-D, Yusuf S, et al. Patient and Healthcare Provider 
Barriers to Hypertension Awareness, Treatment and Follow Up: A 
Systematic Review and Meta-Analysis of Qualitative and Quantitative 
Studies. PLoS One. 2014;9(1):e84238.  
72.  Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. 
Opioids for chronic noncancer pain: prediction and identification of aberrant 
drug-related behaviors: a review of the evidence for an American Pain 
Society and American Academy of Pain Medicine clinical practice guideline. 
J Pain Off J Am Pain Soc. 2009;10(2):131–146.  
73.  Gourlay DL, Heit HA. Universal precautions revisited: managing the 
inherited pain patient. Pain Med. 2009;10 Suppl 2:S115–123.  
	  	  
62 
74.  Alford DP, Cohen ML, Reynolds EE. How would you manage opioid use in 
these three patients?: Grand rounds discussion from Beth Israel Deaconess 
medical center. Ann Intern Med. 2017;166(7):506–513. 
75.  Frank JW, Levy C, Matlock DD, et al. Patients’ Perspectives on Tapering of 
Chronic Opioid Therapy: A Qualitative Study. Pain Med. 2016;17(10):1838–
1847.  
76.  Sullivan MD, Turner JA, DiLodovico C, D’Appollonio A, Stephens K, Chan Y-
F. Prescription Opioid Taper Support for Outpatients With Chronic Pain: A 
Randomized Controlled Trial. J Pain. 2017;18(3):308–318.  
77.  Hoff T, Weller W, DePuccio M. The patient-centered medical home: a review 
of recent research. Med Care Res Rev MCRR. 2012;69(6):619–644.  
78.  Alexander JA, Markovitz AR, Paustian ML, et al. Implementation of Patient-
Centered Medical Homes in Adult Primary Care Practices. Med Care Res 
Rev MCRR. 2015;72(4):438–467.  
79.  Jackson GL, Powers BJ, Chatterjee R, et al. Improving patient care. The 
patient centered medical home. A Systematic Review. Ann Intern Med. 
2013;158(3):169–178.  
80.  Harvey G, Kitson A. PARIHS revisited: from heuristic to integrated 
framework for the successful implementation of knowledge into practice. 
Implement Sci IS. 2016;11. 
81.  Cahill NE, Suurdt J, Ouellette-Kuntz H, Heyland DK. Understanding 
adherence to guidelines in the intensive care unit: development of a 
comprehensive framework. JPEN J Parenter Enteral Nutr. 2010;34(6):616–
624.  
82.  Cabana MD, Kiyoshi-Teo H. The broader picture on guideline adherence. 
JPEN J Parenter Enteral Nutr. 2010;34(6):593–594.  
	  	  
63 
CURRICULUM VITAE 
	   64 
	  	  
65 
	  	  
66 
	  	  
67 
	  	  
68 
	  	  
69 
	  	  
70 
